Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents

Metabolism: Clinical and Experimental

Volumn 55, Issue 10, 2006, Pages 1388-1396

  Kratochvílová, Simona ^a   Vyhnanovská, Pavlína ^a   Vlasáková, Zuzana ^a   Hájek, Milan ^a   Skibová, Jelena ^a   Pelikánová, Terezie ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ESTER DERIVATIVE; INSULIN; MAGNESIUM; PHOSPHATE; PROTON;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HORMONE ACTION; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAGNESIUM BLOOD LEVEL; MALE; METABOLIC CLEARANCE RATE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROGENY; SKELETAL MUSCLE; SOLEUS MUSCLE; SYSTOLIC BLOOD PRESSURE; WHOLE BODY SCANNER;

ADULT; BLOOD GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL;

EID: 33748465898     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.06.010     Document Type: Article

References (60)

1. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
2. Beatty O.L., Harper R., Sheridan B., Atkinson A.B., and Bell P.M. Insulin resistance in offspring of hypertensive parents. BMJ 307 (1993) 92-96
3. Facchini F., Chen Y.D.I., Clinkingbeard C., Jeppesen J., and Reaven G.M. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5 (1992) 694-699
4. Ferrari P., Weidmann P., Shaw S., Giachino D., Riesen W., Allemann Y., et al. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent. Am J Med 91 (1991) 589-596
5. Endre T., Mattiasson I., Hulthen U.L., Lindgarde F., and Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens 12 (1994) 81-88
6. Vlasakova Z., Pelikanova T., Karasova L., and Skibova J. Insulin secretion, sensitivity and metabolic profile of young healthy offspring of hypertensive parents. Metabolism 53 (2004) 469-475
7. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essentials hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88 (2003) 2399-2403
8. Paolisso G., and Barbagallo M. Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 10 (1997) 346-355
9. Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 24 (2003) 39-52
10. Gupta R.K., Benovic J.L., and Rose Z.B. The determination of free magnesium level in the human red blood cell by 31P NMR. J Biol Chem 253 (1978) 6172-6176
11. 2+ during blood storage: detection by 31P nuclear magnetic resonance spectroscopy. Blood 6 (1985) 1526-1530
12. Thompson C.H., Kemp G.J., Sanderson A.L., and Radda G.K. Skeletal muscle mitochondrial function studied by kinetics analysis of postexercise phosphocreatine resynthesis. J Appl Physiol 78 (1995) 231-239
13. Beer M. Cardiac spectroscopy: techniques, indications and clinical results. Eur Radiol 14 (2004) 1034-1047
14. 2+, pH and 31P MR metabolite ratios in calf muscles of healthy controls and patients with primary juvenile hypertension. Physiol Res 51 (2002) 159-167
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
16. European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
17. De Fronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
18. Valk H.W. Magnesium in diabetes mellitus. Neth J Med 54 (1999) 139-146
19. Resnick L.M., Altura B.T., Gupta R.K., Laragh J.H., Alderman M.H., and Altura B.M. Intracellular and extracellular magnesium depletion in type 2 diabetes mellitus. Diabetologie 36 (1993) 767-770
20. Resnick L.M., Gupta R.K., Gruenspan H., and Laragh J.H. Intracellular free magnesium in hypertension: relation to peripheral insulin resistance. Hypertens Suppl 6 (1988) S199-S201
21. Resnick L.M., Gupta R.K., Bhargava K.K., Gruenspan H., Alderman M.H., and Laragh J.H. Cellular ions in hypertension, diabetes and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 17 (1991) 951-957
22. Barbagallo M., Gupta R.K., Dominguez L.J., and Resnick L.M. Cellular ionic alterations with age: relation to hypertension and diabetes. J Am Geriatr Soc 48 (2000) 1111-1116
23. Barbagallo M., Gupta R.K., Bardicef O., Bardicef M., and Resnick L.M. Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. Clin Endocrinol Metab 82 (1997) 1761-1765
24. Corica F., Allegra A., Buemi M., Ientile R., Corsonello A., Bonanzinga S., et al. Obesity and hypertension: the role of magnesium. Recenti Prog Med 84 (1998) 169-176
25. Mo Z., Zhang M., Guan Y., and Jian W. Changes in calcium and magnesium levels of lymphocytes in patients with diabetes and hypertension. Hunan Yi Ke Da Xue Xue Bao 24 (1999) 471-473
26. Resnick L.M., Gupta R.K., and Laragh J.H. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci U S A 81 (1984) 6511-6515
27. 2+ in genetically hypertensive rats. Hiroshima J Med Sci 48 (1999) 1-8
28. Jelicks L.A., and Gupta R.K. NMR measurement of cytosolic free calcium, free magnesium and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat. J Biol Chem 25 (1990) 1394-1400
29. Ng L.L., Davies J.E., and Ameen M. Intracellular free magnesium levels in vascular smooth muscle and striated muscle cells of the spontaneously hypertensive rat. Metabolism 41 (1992) 772-777
30. ++ concentrations in smooth and striated muscle cells in spontaneously hypertensive rats. Am J Hypertens 13 (2000) 427-430
31. Sebekova K., Stefikova K., Krivosikova Z., and Spustova V. 31P NMR investigation of free intracellular magnesium, pH and energy balance in striated muscle of patients with kidney disease: relation to insulin resistance. Bratisl Lek Listy 100 (1999) 411-416
32. Jelicks L.A., and Gupta R.K. Intracellular free magnesium and high energy phosphates in the perfused normotensive and spontaneously hypertensive rat heart. A 31P NMR study. Am J Hypertens 4 (1991) 131-136
33. Resnick L.M., Militianu D., Cunnings A.J., Pipe J.G., Evelhoch J.L., and Soulen R.L. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 30 (1997) 654-659
34. 2+] in single, intact porcine carotid artery segments studied by 31P-NMR. Biochim Biophys Acta 1055 (1990) 27-35
35. Resnick L.M., Barbagallo M., Gupta R.K., and Laragh J.H. Ionic basis of hypertension in diabetes mellitus. Role of hyperglycemia. Am J Hypertens 6 (1993) 413-417
36. Barbagallo M., Dominguez L.J., Bardicef O., and Resnick L.M. Altered cellular magnesium responsiveness to hyperglycemia in hypertensive subjects. Hypertension 38 (2001) 612-615
37. Resnick L.M., Gupta R.K., Gruenspan H., Alderman M.H., and Laragh J.H. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens 3 (1990) 373-379
38. Matuura T., Kohno M., Kanayama Y., Yasunari K., Murakawa K., Takeda T., et al. Decreased intracellular free magnesium in erythrocytes of spontaneously hypertensive rats. Biochem Biophys Res Commun 30 (1987) 1012-1017
39. Touyz R.M., and Milne F.J. Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. Am J Hypertens 12 (1999) 757-765
40. Rodriguez-Moran M., and Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 26 (2003) 1147-1152
41. Hug F., Bendahan D., Fur Y.L., Cozzone P.J., and Grelot L. Metabolic recovery in professional road cyclists: a 31P-MRS study. Med Sci Sports Exerc 37 (2005) 846-852
42. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
43. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350 (2004) 664-671
44. Neubauer S., Horn M., Pabst T., Harre K., Stromer H., Bertsch G., et al. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med 45 (1997) 453-462
45. Schuermann-Freestone M., Madsen P.L., Manners D., Blamire A.M., Buckingham R.E., Styles P., et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107 (2003) 3040-3046
46. Metzler B., Schocke M.F., Steinboeck P., Wolf C., Judmaier W., Lechleitner M., et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 4 (2002) 493-502
47. Diamant M., Lamb H.J., Groeneveld Y., Endert E.L., Smit J.W., Bax J.J., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42 (2003) 328-335
48. Lamb H.J., Beyerbacht H.P., Van der Laarse A., Stoel B.C., Doornbos J., van der Wall E.E., and de Roos A. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99 (1999) 2261-2267
49. Perings S.M., Schulze K., Decking U., Kelm M., and Strauer B.E. Age-related decline of PCr/ATP ratio in progressively hypertrophied hearts of spontaneously hypertensive rats. Heart Vessels 15 (2002) 197-202
50. Carlier P.G., Jacobstein M.D., Portman M.A., Fouad F., Tarazi R.C., and Gerken T.A. Alterations of energy metabolism in the spontaneously hypertensive rat: a 31 P nuclear magnetic resonance study. J Hypertens Suppl 4 (1986) S95-S98
51. Lortet S., Heckmann M., Aussedat J., Ray A., Vincent M., Sassard J., et al. Alteration of cardiac energy state during development of hypertension in rats of the Lyon strain: a 31P NMR study on the isolated rat heart. Acta Physiol Scand 149 (1993) 311-321
52. Miller D.D., and Walsh R.A. In vivo phosphorus-31 NMR spectroscopy of abnormal myocardial high-energy phosphate metabolism during cardiac stress in hypertensive-hypertrophied non-human primates. Int J Card Imaging 6 (1990-1991) 57-70
53. Beer M., Seyfarth T., Sandstede J., Landschutz W., Lipke C., Kostler H., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40 (2002) 1267-1274
54. Ronquist G., Soussi B., Frithz G., Schersten T., and Waldenstorm A. Disturbed energy balance in skeletal muscle of patients with untreated primary hypertension. J Intern Med 238 (1995) 167-174
55. Taylor D.J., Coppack S.W., Cadoux-Hudson T.A.D., Kemp G.J., Radda G.K., Frayn K.N., et al. Effect of insulin on intracellular pH and phosphate metabolism in human skeletal muscle in vivo. Clin Sci 81 (1991) 123-128
56. Fisher M.J., and Dillon P.F. 31P NMR study of insulin effects on the isolated perfused rabbit urinary bladder. Magn Reson Med 9 (1989) 53-65
57. Altura B.M., Barbour R.L., Dowd T.L., Wu F., Altura B.T., and Gupta R.K. Low extracellular magnesium induces intracellular free Mg deficits, ischemia, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: a 31P-NMR study. Biochim Biophys Acta 1182 (1993) 329-332
58. Resnick L.M., Gupta R.K., Barbagallo M., and Laragh J.H. Is the higher incidence of ischemic heart disease in patients with hypertension and diabetes related to intracellular depletion of high energy metabolites?. Am J Med Sci 307 (1994) S66-S69
59. Kurkova D., Hajek M., Havlova M., and Grosmanova A. Use of in vivo MR spectroscopy in investigations of skeletal muscles of man. Cesk Radiol 5 (1997) 305-310
60. McCully K., Mancini D., and Levine S. Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems. Chest 5 (1999) 1434-1441